Iris Coleman
May 12, 2026 21:48
Injective (INJ)USDC becomes the canonical stablecoin across Cosmos and dYdX, solidifying Injective as a major blockchain for stablecoin issuance.
Injective (INJ)USDC has been designated as the canonical stablecoin standard for both the Cosmos ecosystem and dYdX, marking a major milestone for the Injective blockchain. This decision makes Injective one of the largest platforms for stablecoin issuance and paves the way for a unified, long-term stablecoin infrastructure across these networks.
The move includes a four-year minimum commitment from Cosmos and dYdX, signaling confidence in Injective’s ability to provide a stable and reliable issuance layer. With this integration, every USDC dollar within these ecosystems will be issued via the Injective blockchain, eliminating fragmentation caused by bridged or wrapped variants.
Why This Matters
Stablecoins like USDC are central to decentralized finance (DeFi), enabling payments, swaps, and treasury management. By standardizing on Injective USDC, Cosmos chains and applications gain a known, permanent issuer and native infrastructure. This reduces costs and operational complexity while ensuring a consistent experience for users and developers alike.
dYdX, the largest perpetuals DEX on Cosmos, will be the first platform to adopt Injective USDC. With over $4 billion in monthly trading volume, dYdX’s integration underscores the importance of a reliable stablecoin source. All collateral, settlements, and funding rate flows on the platform will now be backed by Injective USDC.
A Response to Noble’s Exit
The announcement follows Noble’s earlier decision to leave Cosmos, which left the ecosystem without a long-term USDC issuer. Injective fills this gap, inheriting over $100 million in issuance and providing stability for Cosmos applications. This continuity is crucial for builders and institutions that rely on predictable infrastructure for deploying capital.
Skip Protocol and Interoperability
Skip Protocol’s routing layer, Skip:Go, will make Injective USDC the default denomination for interchain transfers across Cosmos. Additionally, Injective’s support for Circle’s Cross-Chain Transfer Protocol (CCTP) enables seamless USDC transfers between Injective and other supported blockchains. As of late 2025, CCTP processed $126 billion in cumulative volume, highlighting its importance in the stablecoin ecosystem.
USDC’s Broader Impact
USDC ended 2025 with $79 billion in circulation and $11.9 trillion in quarterly on-chain transaction volume. The stablecoin market as a whole grew to $315 billion in market capitalization, with transaction volumes exceeding $33 trillion in 2025. This growth reflects increasing adoption, particularly in B2B payments and institutional finance, where stablecoins are becoming integral to the financial system.
Why Injective?
Injective’s technical capabilities make it a natural choice for this role. The blockchain offers 0.64-second block times, transaction fees as low as $0.00008, and native interoperability with IBC, Ethereum, and Solana. Its MultiVM environment also supports a wide range of DeFi applications. Institutional backing from players like Google Cloud, Binance, and Paxos further strengthens its credibility.
Looking Ahead
The migration to Injective USDC is already underway, with dYdX leading the charge. Additional Cosmos chains and applications will follow in the coming months, coordinated by Cosmos Labs. For developers and projects, Injective USDC is now positioned as the de facto stablecoin standard within this ecosystem.
This move solidifies Injective’s role as a key player in the stablecoin and DeFi sectors, setting the stage for further growth and adoption in the years ahead.
Image source: Shutterstock
Credit: Source link
